Although myopia can be corrected with spectacles, contact lenses, or refractive surgery, the costs of treating myopia and its associated comorbidities, including glaucoma, rhegmatogenous retinal detachment, and chorioretinal atrophy, can be considerable and are conservatively estimated to be in excess of $4.6 billion dollars in the United States.
1,2 In the United Kingdom alone there are approximately 200,000 people with pathological myopia (National Institute for Health and Care Excellence, available in the public domain at
http://www.nice.org.uk/guidance/ta298/resources/choroidal-neovascularisation-pathological-myopia-ranibizumab-draft-scope-pre-referral2, date accessed July 9, 2014). Therefore, there is considerable interest in the identification of risk factors for myopia
3 as modifying these risk factors may lessen the prevalence and impact of myopia. Many genetic and environmental factors have been shown to be associated with the prevalence of myopia, including higher educational attainment,
4 greater amounts of near work,
4,5 socioeconomic status,
6,7 body stature,
8 degree of urbanization,
9 level of physical activity,
10 level of outdoor activity,
3 low birth weight,
11 parental smoking status,
12 parental education and birth order,
13 and lack of breastfeeding.
14 Family history of myopia (Williams C, et al.
IOVS 2005;46:ARVO E-Abstract 4622 and Refs.
15–
17) and ethnicity (Williams C, et al.
IOVS 2005;46:ARVO E-Abstract 4622 and Ref.
15,
18,
19) also are recognized risk factors for myopia and associations with age and sex also have been described.
20 Numerous narrative reviews describe these risk factors in some detail.
21–24